Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators’ viewpoint

According to the ESC guidelines, cangrelor may be considered in P2Y12-inhibitor-naïve acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). The aim of this review is to summarize available evidence on the optimal maintenance therapy with P2Y12 receptor inhibitor...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Jacek Kubica, Piotr Adamski, Robert Gajda, Aldona Kubica, Małgorzata Ostrowska, Gavino Casu, Diana A. Gorog, Paul A. Gurbel, Tomasz Hajdukiewicz, Miłosz Jaguszewski, Young-Hoon Jeong, Agata Kosobucka-Ozdoba, Zuzana Motovska, Piotr Niezgoda, Maciej Piasecki, Przemysław Podhajski, Paolo Raggi, Uzeyir Rahimov, Jolanta M. Siller-Matula, Grzegorz Skonieczny, Łukasz Szarpak, Paweł Szymański, Udaya Tantry, Eliano P. Navarese
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Via Medica 2025-02-01
Serie:	Cardiology Journal
Ämnen:	antiplatelet therapy cangrelor ticagrelor P2Y12 receptor inhibition
Länkar:	https://journals.viamedica.pl/cardiology_journal/article/view/98323
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!